BOARD OF PHARMACY- REGULATORY UPDATE. Kimberly Grinston, J.D., Executive Director

Size: px
Start display at page:

Download "BOARD OF PHARMACY- REGULATORY UPDATE. Kimberly Grinston, J.D., Executive Director"

Transcription

1

2 BOARD OF PHARMACY- REGULATORY UPDATE Kimberly Grinston, J.D., Executive Director

3 Disclosure and Conflict of Interest I declare no conflicts of interest, real or apparent, and no financial interest in any company, product, or service mentioned in this program, including grants, employment, gifts, stock holdings and honoraria.

4 Pharmacist Objectives At the conclusion of this program, the pharmacist will be able to: 1. Identify new rule/legislative compliance requirements 2. Develop needed compliance policies and procedures 3. Identify new inspection/compliance resources

5 Technician Objectives At the conclusion of this program, the technician will be able to: 1. Identify new legislative changes 2. Identify recent rule changes 3. Identify applicable Board resources

6 Pre-Test Questions All vaccines must comply with CDC guidelines TRUE FALSE Pharmacists can dispense epinephrine auto-injectors to any county parks department TRUE FALSE Pharmacists are required to notify the Board before dispensing naloxone under the standing order and complete all training requirements TRUE FALSE

7 Missouri Board of Pharmacy Regulatory Update

8 Legislative Changes (2017) SB 50 SB 139 SB 501

9 SB 501 Immunization Changes Epinephrine Sales Hospital Pharmacy Drug Take Back Program Naloxone Dispensing

10 SB 501 (Vaccines & CDC Compliance) Vaccines administered by protocol must comply with CDC guidelines Vaccines administered by medical prescription order must comply with CDC guidelines or manufacturer guidelines Effective August 28, 2017

11 SB 139 (Epinephrine Dispensing) Allows pharmacies to dispense epinephrine to an authorized entity with an Rx in the name of the entity [Sec ] Authorized Entity : Any entity or organization at or in connection with which allergens capable of causing anaphylaxis may be present including, but not limited to, restaurants, recreation camps, youth sports leagues, amusement parks, and sports arenas.

12 SB 139 (Epinephrine Dispensing) Similar to current law for nurses & school districts Rx can only be issued by a Missouri licensed physician & not a APRN or PA/AP. Rx must be in the name of the authorized entity [Sec ] Required 2-line format

13 SB 139 (Epinephrine Dispensing) Treated the same as a non-controlled Rx (Valid for 1-year, refills/quantity limits as prescribed)

14 SB 139 (Epinephrine Dispensing) Mandatory Training for expected auto-injector users Does not apply to pharmacists normally dispensing from regular inventory No additional pharmacist training required unless the medication was received based on a Rx issued to the pharmacy under

15 SB 139 (Epinephrine Dispensing) Can pharmacists provide the required training? Expected epinephrine auto-injector users [must] receive training in recognizing symptoms of severe allergic reactions including anaphylaxis and the use of epinephrine auto-injectors from a nationally recognized organization experienced in training laypersons in emergency health treatment or another entity or person approved by the department of health and senior services. Contact Department of Health

16 SB 501/SB 50 (Hospital Pharmacy) Missouri hospitals deemed in compliance with Chapter 197 licensing requirements if they comply with the Medicare conditions of participation [Sec ] Preempts designated hospital licensure rules that duplicate or conflict with Medicare COPs. DHSS reviewing the impact on hospital pharmacies [July 1, 2018 effective date]

17 SB 501 (Drug Take-Back Program) Authorizes the Board to develop and fund a drug take-back program with DHSS. Specifically includes Schedule II & III Updates provided in the future

18 SB 501 (Naloxone Dispensing) Allows pharmacists to dispense naloxone under a statewide protocol without a Rx Statewide protocol signed by DHSS Director Effective August 28, 2017

19 SB 501 (Naloxone Dispensing) See August Newsletter for complete information Naloxone Webinar September 12, 2017

20 SB 501 (Naloxone Dispensing) Any Missouri licensed pharmacist can participate in the standing order Standing order is a prewritten medication order that authorizes healthcare practitioners to perform designated activities. Standing order issued by DHSS Director, Dr. Randall Williams, M.D. No Rx needed

21 SB 501 (Naloxone Dispensing) No additional pharmacist training or certification required Notification/Registration not required Physician protocol is optional

22 SB 501 (Naloxone Dispensing) Standing Order allows dispensing to any eligible candidate Anyone who voluntarily requests naloxone or is at risk of an overdose or in a position to assist someone at risk

23 SB 501 (Naloxone Dispensing) Quantity Limits defined in the Standing Order Patient Education Mandatory Can be treated as an Rx or as a distribution Does not currently include Evzio

24 SB 501 (Naloxone Dispensing) If an Rx, comply with all Rx requirements If a distribution, patient name recommended but not required.

25 SB 501 (Naloxone Dispensing) Distribution: The transaction date Product name, strength & dosage form Quantity Distribution records 2 years; Rx records 5 years

26 SB 501 (Naloxone Dispensing) Insurance questions Depends on the plan MoHealthNet may allow reimbursement

27 SB 139 (Rx Cares for Missouri) Program) Authorizes the Board to establish a program to promote medication safety and to prevent prescription drug abuse, misuse, and diversion in Missouri Collaboration with DHSS Allows private and public funding

28 RULE CHANGES

29 Rule Review Executive Order Requires state agencies to review all rules Board has held 3 open meetings; Next meetings September & October 2017

30 Rule Review Board initiated its own comprehensive rule review in 2016 Revising and Updating Rules

31 Rule Review Topic: Remote Technician Supervision/Final Product Verification Automated Dispensing Systems (including patient self-service machines) Automated Distribution Models Drug Utilization Review

32 Rule Review Topic: Technology Usage Decreasing Paperwork Licensee Identification Other Patient Safety Proposals

33 Rule Changes Class-J Shared Services Rule (20 CSR ) Emergency Rule Effective August 6, 2-17 Proposed Rule Pending

34 20 CSR (Class-J) Caution! The emergency exemption does not exempt entities from all Board licensure. The emergency rule only exempts licensed Missouri pharmacies from having an additional Class J designation.

35 20 CSR (Class-J) What is administration? Applying or introducing medication to the body of a patient, whether by injection, infusion, inhalation, ingestion or other means.

36 Additional Exemption Requirements Receiving pharmacy documentation: Name and address of pharmacy providing medication Date of receipt of medication Patient name

37 Examples A pharmacy located within an infusion center Patient assistance programs Specialty drugs Restricted access drugs A community pharmacy administering to patients by medical prescription order Long acting injectable antipsychotics Specialty drugs

38 Additional Exemption Requirements If additional compounding or manipulation required by receiving pharmacy: Need valid prescription or medication order Must dispense as if its own prescription Must follow Board s requirements for; a. Prescriptions/medication orders b. Record keeping c. Compounding d. Labeling

39 Additional Exemption Requirements Patient counseling Receiving pharmacy responsible for patient counseling requirements Pharmacist administration by medical order 20 CSR Need separate medical order to administer Cannot rely on order from other pharmacy

40 Post Test: Question #1 Pharmacists can dispense epinephrine auto-injectors to any county parks department TRUE FALSE

41 Post Test: Question #1 Pharmacists can dispense epinephrine auto-injectors to any county parks department FALSE- Need a Rx

42 Post Test: Question #1 Pharmacists can dispense epinephrine auto-injectors to any county parks department FALSE- Need a Rx

43 Post Test: Question #2 Pharmacist administered vaccines must comply with CDC guidelines TRUE FALSE

44 Post Test: Question #2 Pharmacist administered vaccines must comply with CDC guidelines FALSE- CDC or Manufacturer s Guidelines if Administering by Rx Order

45 Post Test: Question #3 Pharmacists are required to notify the Board before dispensing naloxone under the standing order and complete all training requirements TRUE FALSE

46 Post Test: Question #3 Pharmacists are required to notify the Board before dispensing naloxone under the standing order and complete all training requirements FALSE Any licensed pharmacist can sell/dispense naloxone under the Standing Order

47 Take Home Points 1. New laws effective Pharmacists have options for dispensing/selling naloxone 3. Monitor the Board s website for new & proposed rules

48 Resources & References 1) August Newsletter 2) Board s Website (Rules & 2017 Legislation) 3) Naloxone Resource Center

49 Speaker Contact Information Kimberly Grinston Missouri Bd. of Pharmacy (573)

Missouri Board Of Pharmacy

Missouri Board Of Pharmacy Missouri Board Of Pharmacy Today s webinar topics Ø2018 Legislative changes ØRegulation updates ØQ & A DISCLAIMER ***This presentation summarizes key legislation and does not include all legislation that

More information

Dispensing and administration of emergency opioid antagonist without a

Dispensing and administration of emergency opioid antagonist without a 68-7-23. Dispensing and administration of emergency opioid antagonist without a prescription. (a) A pharmacist may dispense an FDA-approved emergency opioid antagonist and the necessary medical supplies

More information

Sub. S.B. 119 As Passed by the Senate

Sub. S.B. 119 As Passed by the Senate AM3404 Sub. S.B. 119 As Passed by the Senate Topic: Opioid Data and Communication Expansion Act moved to amend as follows: In line 1 of the title, after "4723.52," insert "4729.01, 4729.44, 4729.75, 4729.79,

More information

Be it enacted by the People of the State of Illinois,

Be it enacted by the People of the State of Illinois, AN ACT concerning education. Be it enacted by the People of the State of Illinois, represented in the General Assembly: Section 5. The School Code is amended by changing Section 22-30 as follows: (105

More information

ISSUING AGENCY: Regulation and Licensing Department - Board of Pharmacy, Albuquerque, NM. [ NMAC - N, ; A, ]

ISSUING AGENCY: Regulation and Licensing Department - Board of Pharmacy, Albuquerque, NM. [ NMAC - N, ; A, ] TITLE 16 CHAPTER 19 PART 26 OCCUPATIONAL AND PROFESSIONAL LICENSING PHARMACISTS PHARMACIST PRESCRIPTIVE AUTHORITY 16.19.26.1 ISSUING AGENCY: Regulation and Licensing Department - Board of Pharmacy, Albuquerque,

More information

Michigan Legislative and Regulatory Pharmacy Initiatives Update

Michigan Legislative and Regulatory Pharmacy Initiatives Update Michigan Legislative and Regulatory Pharmacy Initiatives Update Michigan Association of Health Plans Summer Conference Carrie Germain, R.Ph. Health Alliance Plan Senior Director, Pharmacy, Quality and

More information

Prescription Monitoring Program (PMP)

Prescription Monitoring Program (PMP) 06/15/2018 FACT SHEET Implementation of Enacted Prescribing Limits and Requirements and Relevant Opioid Prescribing Laws and Rules Background: The 2016 law (Chapter 488) makes five major changes to opioid

More information

Pharmacy Law Disclosure Statement. Objectives 6/11/2016. I have no conflicts of interest to disclose related to this presentation.

Pharmacy Law Disclosure Statement. Objectives 6/11/2016. I have no conflicts of interest to disclose related to this presentation. Pharmacy Law 2016 Ronda H. Lacey, J.D., M.S. Pharm Disclosure Statement I have no conflicts of interest to disclose related to this presentation. Objectives At the conclusion of this continuing education

More information

DRUG PRODUCT INTERCHANGEABILITY AND PRICING ACT

DRUG PRODUCT INTERCHANGEABILITY AND PRICING ACT c t DRUG PRODUCT INTERCHANGEABILITY AND PRICING ACT PLEASE NOTE This document, prepared by the Legislative Counsel Office, is an office consolidation of this Act, current to September 22, 2014. It is intended

More information

Illinois Prescription Monitoring Program. Sarah Pointer, Pharm D. Clinical Director of the Illinois Prescription Monitoring Program

Illinois Prescription Monitoring Program. Sarah Pointer, Pharm D. Clinical Director of the Illinois Prescription Monitoring Program Illinois Prescription Monitoring Program Sarah Pointer, Pharm D. Clinical Director of the Illinois Prescription Monitoring Program Agenda Provide an overview of the Illinois Prescription Monitoring Program

More information

TEXAS COMPASSIONATE-USE ACT

TEXAS COMPASSIONATE-USE ACT Ch. 301, 1 MEDICAL USE OF LOW-THC CANNABIS AND THE REGULATION OF RELATED ORGANIZATIONS AND INDIVIDUALS; REQUIRING A DISPENSING ORGANIZATION TO OBTAIN A LICENSE TO DISPENSE LOW-THC CANNABIS AND ANY EMPLOYEE

More information

11/11/2015. MVAs Suicide Firearms Homicide. Where Can I Find A Copy of the PDMP Law? Why Was the Law Established? Why Was the Law Established?

11/11/2015. MVAs Suicide Firearms Homicide. Where Can I Find A Copy of the PDMP Law? Why Was the Law Established? Why Was the Law Established? Where Can I Find A Copy of the PDMP Law? Alabama Uniform Controlled Substances Act Code of Alabama 1975 20-2- (Article 10) -210 through 220 and Rules 420-7-2-.11 through.13 1 Why Was the Law Established?

More information

SUPPLEMENTAL NOTE ON HOUSE BILL NO. 2217

SUPPLEMENTAL NOTE ON HOUSE BILL NO. 2217 SESSION OF 2017 SUPPLEMENTAL NOTE ON HOUSE BILL NO. 2217 As Amended by House Committee on Health and Human Services Brief* HB 2217, as amended, would enact new law and amend the Kansas Pharmacy Act (Act)

More information

North Dakota Board of Pharmacy

North Dakota Board of Pharmacy North Dakota Board of Pharmacy Updates on Drug Abuse Trends, the PDMP and Medical Marijuana Mark J. Hardy, Pharm D Executive Director Disclosure Statement I have no conflict of interests to report Objectives

More information

PROPOSED AMENDMENTS TO HOUSE BILL 3440

PROPOSED AMENDMENTS TO HOUSE BILL 3440 HB 0- (LC ) // (MBM/ps) Requested by Representative WILLIAMSON PROPOSED AMENDMENTS TO HOUSE BILL 0 1 On page 1 of the printed bill, line, delete 1A. and. Delete lines through and pages through and insert:

More information

PLEASE NOTE. For more information concerning the history of this Act, please see the Table of Public Acts.

PLEASE NOTE. For more information concerning the history of this Act, please see the Table of Public Acts. PLEASE NOTE This document, prepared by the Legislative Counsel Office, is an office consolidation of this Act, current to July 1, 2012. It is intended for information and reference purposes only. This

More information

CRITICAL POLICY REFERENCE MANUAL FILE CODE: X Monitored X Mandated Sample Policy X Other Reasons

CRITICAL POLICY REFERENCE MANUAL FILE CODE: X Monitored X Mandated Sample Policy X Other Reasons CRITICAL POLICY REFERENCE MANUAL FILE CODE: 5141.21 X Monitored X Mandated Sample Policy X Other Reasons ADMINISTERING MEDICATION The board shall not be responsible for the diagnosis and treatment of student

More information

4/26/2018. Bureau of Professional Licensing. MAPS Updates & Opportunities. MAPS Background. Registration. MAPS Update

4/26/2018. Bureau of Professional Licensing. MAPS Updates & Opportunities. MAPS Background. Registration. MAPS Update Bureau of Professional Licensing MAPS Updates & Opportunities April 28, 2018 Presented by Andrew Hudson, Manager Haley Winans, Analyst Drug Monitoring Section Bureau of Professional Licensing BPL-MAPS@Michigan.gov

More information

PRESCRIPTION DRUG MONITORING PROGRAM

PRESCRIPTION DRUG MONITORING PROGRAM PRESCRIPTION DRUG MONITORING PROGRAM ST. LOUIS COUNTY Q2 2017 Contents Executive Summary... 2 User Registration & System Utilization... 4 Dispensation Rates... 6 Dispensation Rates by Geography... 6 Dispensation

More information

Performance of North Carolina's System for Monitoring Prescription Drug Abuse. Session Law , Section 12F.16.(q)

Performance of North Carolina's System for Monitoring Prescription Drug Abuse. Session Law , Section 12F.16.(q) Performance of North Carolina's System for Monitoring Prescription Drug Abuse Session Law 2015-241, Section 12F.16.(q) Report to the Joint Legislative Oversight Committee on Health and Human Services and

More information

[First Reprint] ASSEMBLY, No STATE OF NEW JERSEY. 217th LEGISLATURE INTRODUCED FEBRUARY 4, 2016

[First Reprint] ASSEMBLY, No STATE OF NEW JERSEY. 217th LEGISLATURE INTRODUCED FEBRUARY 4, 2016 [First Reprint] ASSEMBLY, No. STATE OF NEW JERSEY th LEGISLATURE INTRODUCED FEBRUARY, 0 Sponsored by: Assemblyman DANIEL R. BENSON District (Mercer and Middlesex) Assemblywoman VALERIE VAINIERI HUTTLE

More information

Public Health Impacts of 2016 West Virginia Legislation

Public Health Impacts of 2016 West Virginia Legislation Public Health Impacts of 2016 West Virginia Legislation Sherri A. Young, DO, FAAFP WVSOM Summer Seminar North Myrtle Beach, South Carolina June 15, 2016 1 Objectives Passage and implementation of Expedited

More information

2017 Legislative Policy Update

2017 Legislative Policy Update 2017 Legislative Policy Update Aliyah N. Horton, CAE Executive Director Maryland Pharmacists Association Presentation Overview Maryland Pharmacists Association General highlights of the session Pharmacy-related

More information

Medicare Advantage Outreach and Education Bulletin

Medicare Advantage Outreach and Education Bulletin Medicare Advantage Outreach and Education Bulletin Blue Cross and Blue Shield of Georgia Prescription Drug Monitoring Programs Prescription drug abuse and diversion are acute problems in the area of pain

More information

PHARMACY 543 PHARMACY LAWS & ETHICS MIDTERM EXAMINATION October 29, 1998

PHARMACY 543 PHARMACY LAWS & ETHICS MIDTERM EXAMINATION October 29, 1998 PHARMACY 543 PHARMACY LAWS & ETHICS MIDTERM EXAMINATION October 29, 1998 Questions 1 20 are multiple choice; please record answers on Side 2 of a Standard Answer Sheet, Form 1158. Follow the instructions

More information

Naloxone Access Statutes

Naloxone Access Statutes Naloxone Access Statutes Research current through March 1, 2016 This project was supported by Grant No. G15599ONDCP03A, awarded by the Office of National Drug Control Policy. Points of view or opinions

More information

Why pay for Continuing Education when you can get it for FREE!?

Why pay for Continuing Education when you can get it for FREE!? Why pay for Continuing Education when you can get it for FREE!? Special Projects Coordinator Arizona Center for Rural Health 9/15/17 This publication was supported by the Grant Number 1U17CE002717-01,

More information

ASSEMBLY, No STATE OF NEW JERSEY. 216th LEGISLATURE INTRODUCED MAY 15, 2014

ASSEMBLY, No STATE OF NEW JERSEY. 216th LEGISLATURE INTRODUCED MAY 15, 2014 ASSEMBLY, No. STATE OF NEW JERSEY th LEGISLATURE INTRODUCED MAY, 0 Sponsored by: Assemblyman RONALD S. DANCER District (Burlington, Middlesex, Monmouth and Ocean) Assemblyman HERB CONAWAY, JR. District

More information

The Opioid Crisis: Effectiveness of State Responses

The Opioid Crisis: Effectiveness of State Responses The Opioid Crisis: Effectiveness of State Responses Gordon H. Smith, Esq. Maine Medical Association American Society of Medical Association Counsel Mauna Lani Bay, November 2017 Opioids: the difficult

More information

Louisiana. Prescribing and Dispensing Profile. Research current through November 2015.

Louisiana. Prescribing and Dispensing Profile. Research current through November 2015. Prescribing and Dispensing Profile Louisiana Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points

More information

SECTION PRESCRIPTIONS

SECTION PRESCRIPTIONS SECTION.1800 - PRESCRIPTIONS 21 NCAC 46.1801 EXERCISE OF PROFESSIONAL JUDGMENT IN FILLING PRESCRIPTIONS (a) A pharmacist or device and medical equipment dispenser shall have a right to refuse to fill or

More information

Medicare Advantage Outreach and Education Bulletin

Medicare Advantage Outreach and Education Bulletin Medicare Advantage Outreach and Education Bulletin Anthem Blue Cross and Blue Shield Prescription Drug Monitoring Programs Prescription drug abuse and diversion are acute problems in the area of pain management.

More information

Innovative Ways to Fund Harm Reduction Services New Mexico

Innovative Ways to Fund Harm Reduction Services New Mexico Innovative Ways to Fund Harm Reduction Services New Mexico Laine M. Snow, MSW HIV Service Program Manager New Mexico Department of Health History and Importance of Harm Reduction New Mexico Sero-prevalence

More information

EMERGENCY DEPARTMENT MODEL PRACTICES DEALING WITH THE PRESCRIPTION OPIOID EPIDEMIC

EMERGENCY DEPARTMENT MODEL PRACTICES DEALING WITH THE PRESCRIPTION OPIOID EPIDEMIC EMERGENCY DEPARTMENT MODEL PRACTICES DEALING WITH THE PRESCRIPTION OPIOID EPIDEMIC RAMI R KHOURY, MD, FACEP ASSISTANT MEDICAL DIRECTOR EMERGENCY CARE ALLEGIANCE HEALTH ADVERTISING AT ITS BEST! OVERDOSE

More information

Prescription Opioid Overdose in Oregon: A public health perspective

Prescription Opioid Overdose in Oregon: A public health perspective Prescription Opioid Overdose in Oregon: A public health perspective Katrina Hedberg, MD, MPH Health Officer & State Epidemiologist Oregon Public Health Division Oregon Health Authority All-Cause Mortality,

More information

WHAT YOU NEED TO KNOW TO ABOUT AB 474

WHAT YOU NEED TO KNOW TO ABOUT AB 474 WHAT YOU NEED TO KNOW TO ABOUT AB 474 PRESENTED BY: NEVADA STATE BOARD OF OSTEOPATHIC MEDICINE 2275 Corporate Circle, Suite 210 Henderson, NV 89074 702-732-2147 Fax 702-732-2079 Web Site: www.bom.nv.gov

More information

Michigan Opioid Legislation Hospital Compliance Checklist

Michigan Opioid Legislation Hospital Compliance Checklist MHA KEYSTONE CENTER MICHIGAN OPIOID LEGISLATION HOSPITAL COMPLIANCE CHECKLIST The Michigan Opioid Legislation was created by the Michigan Health & Hospital Association to help guide its member hospitals

More information

GENERAL ASSEMBLY OF NORTH CAROLINA SESSION HOUSE BILL DRH20012-MGfa-35H* (01/26)

GENERAL ASSEMBLY OF NORTH CAROLINA SESSION HOUSE BILL DRH20012-MGfa-35H* (01/26) H GENERAL ASSEMBLY OF NORTH CAROLINA SESSION HOUSE BILL DRH0-MGfa-H* (01/) H.B. Mar, HOUSE PRINCIPAL CLERK D Short Title: Strengthen Opioid Misuse Prevention (STOP)Act. (Public) Sponsors: Referred to:

More information

HEB Pharmacy Conference October 25, 2014

HEB Pharmacy Conference October 25, 2014 Texas State Board of Pharmacy Laws and Rules Update Allison Benz, R.Ph., M.S. Director of Professional Services Central Texas Society of Health-System Pharmacists Annual Seminar October 25, 2014 Texas

More information

Proposed Revision to Med (i)

Proposed Revision to Med (i) Proposed Revision to Med 501.02 (i) I. Purpose This rule has been adopted to enable the Board to best protect public health and safety while providing a framework for licensees to effectively treat and

More information

ASSEMBLY, No. 542 STATE OF NEW JERSEY. 218th LEGISLATURE PRE-FILED FOR INTRODUCTION IN THE 2018 SESSION

ASSEMBLY, No. 542 STATE OF NEW JERSEY. 218th LEGISLATURE PRE-FILED FOR INTRODUCTION IN THE 2018 SESSION ASSEMBLY, No. STATE OF NEW JERSEY th LEGISLATURE PRE-FILED FOR INTRODUCTION IN THE 0 SESSION Sponsored by: Assemblyman VINCENT MAZZEO District (Atlantic) Assemblyman JOSEPH A. LAGANA District (Bergen and

More information

Prepublication Requirements

Prepublication Requirements Issued Prepublication Requirements The Joint Commission has approved the following revisions for prepublication. While revised requirements are published in the semiannual updates to the print manuals

More information

10/20/14& the administration of nasal naloxone by school nurses. for nasal naloxone

10/20/14& the administration of nasal naloxone by school nurses. for nasal naloxone Mary Ann Gapinski, MSN, RN, NCSN Director of School Health Services MDPH I do not have a financial relationship or interest in any proprietary entity producing health care goods or services related to

More information

Opioid Abuse and Prescribing. Dr. Mitchell Mutter Director of Special Projects

Opioid Abuse and Prescribing. Dr. Mitchell Mutter Director of Special Projects Opioid Abuse and Prescribing Dr. Mitchell Mutter Director of Special Projects Auburn University February 22, 2019 Disclosure Statement of Financial Interest I, Mitchell Mutter, DO NOT have a financial

More information

FAQs about Changes to DHR Immunization Rules and Regulations

FAQs about Changes to DHR Immunization Rules and Regulations FAQs about Changes to DHR Immunization Rules and Regulations 1. What are the new immunization rules changes? The new immunization rules changes include 1 new definition and changes in 4 vaccine requirements.

More information

Our Journey to Addressing the PA PDMP Program. Dean Parry, RPh AVP Clinical Informatics, Care Support Services Geisinger Health System

Our Journey to Addressing the PA PDMP Program. Dean Parry, RPh AVP Clinical Informatics, Care Support Services Geisinger Health System Our Journey to Addressing the PA PDMP Program Dean Parry, RPh AVP Clinical Informatics, Care Support Services Geisinger Health System 1 Geisinger Health System Geisinger Health System is an integrated

More information

Naloxone and Combating the Opioid Epidemic

Naloxone and Combating the Opioid Epidemic Objectives Naloxone and Combating the Opioid Epidemic Jeff Jacobson PharmD Southpointe Pharmacy Discuss the current opioid crisis Define the role of Naloxone in opioid overdose Analyze the barriers to

More information

PRESCRIPTION DRUG MONITORING PROGRAM ST. CHARLES COUNTY Q1 2018

PRESCRIPTION DRUG MONITORING PROGRAM ST. CHARLES COUNTY Q1 2018 PRESCRIPTION DRUG MONITORING PROGRAM ST. CHARLES COUNTY Q1 2018 Contents Executive Summary... 2 User Registration & System Utilization... 4 Dispensation Rates... 6 Dispensation Rates by Geography... 6

More information

SELF-ADMINISTERED MEDICATION AND EPINEPHRINE USE

SELF-ADMINISTERED MEDICATION AND EPINEPHRINE USE COUNTY SCHOOLS 5330.02/page 1 of 7 REPLACEMENT POLICY - VOL. 8, NO. 2 SELF-ADMINISTERED MEDICATION AND EPINEPHRINE USE A student may carry and self-administer a metered dose inhaler, epinephrine auto injector,

More information

Naloxone Standardized Procedures Illinois Departments of DFPR, DPH & DHS Opioid Antagonist Initiative

Naloxone Standardized Procedures Illinois Departments of DFPR, DPH & DHS Opioid Antagonist Initiative Naloxone Standardized Procedures Illinois Departments of DFPR, DPH & DHS Opioid Antagonist Initiative Background: In September 2015, Illinois passed a new law, PA99-0480, expanding access to the opioid

More information

REGULATORY IMPACT STATEMENT and COST-BENEFIT ANALYSIS (RISCBA)

REGULATORY IMPACT STATEMENT and COST-BENEFIT ANALYSIS (RISCBA) State Budget Office Office of Regulatory Reinvention 111 S. Capitol Avenue; 8th Floor, Romney Building Lansing, MI 48933 Phone: (517) 335-8658 FAX: (517) 335-9512 REGULATORY IMPACT STATEMENT and COST-BENEFIT

More information

OCCUPATIONAL AND PROFESSIONAL LICENSING MEDICINE AND SURGERY PRACTITIONERS MANAGEMENT OF PAIN AND OTHER CONDITIONS WITH CONTROLLED SUBSTANCES

OCCUPATIONAL AND PROFESSIONAL LICENSING MEDICINE AND SURGERY PRACTITIONERS MANAGEMENT OF PAIN AND OTHER CONDITIONS WITH CONTROLLED SUBSTANCES TITLE 16 CHAPTER 10 PART 14 OCCUPATIONAL AND PROFESSIONAL LICENSING MEDICINE AND SURGERY PRACTITIONERS MANAGEMENT OF PAIN AND OTHER CONDITIONS WITH CONTROLLED SUBSTANCES 16.10.14.1 ISSUING AGENCY: New

More information

Arkansas Department of Health

Arkansas Department of Health Arkansas Department of Health 4815 West Markham Street Little Rock, Arkansas 72205-3867 Telephone (501) 661-2000 Governor Mike Beebe Nathaniel Smith, MD, MPH, Interim Director and State Health Officer

More information

Confronting the Opioid Epidemic

Confronting the Opioid Epidemic Confronting the Opioid Epidemic Appropriately Treating Pain while Stopping Abuse Scott Kennedy, MD, Chief Medical Officer, Olympic Medical Center Ian Corbridge, RN, Clinical Policy Director, WSHA June

More information

79th OREGON LEGISLATIVE ASSEMBLY Regular Session. Enrolled. House Bill 3440

79th OREGON LEGISLATIVE ASSEMBLY Regular Session. Enrolled. House Bill 3440 79th OREGON LEGISLATIVE ASSEMBLY--2017 Regular Session Enrolled House Bill 3440 Sponsored by Representatives WILLIAMSON, BUEHLER, GREENLICK, HERNANDEZ, KENNEMER, MALSTROM, MEEK, Senator STEINER HAYWARD;

More information

Legal Considerations for. Immunizations

Legal Considerations for. Immunizations Legal Considerations for Pharamcists Providing Immunizations Gary G. Cacciatore, Pharm.D., J.D. Vice President of Regulatory Affairs and Associate Chief Regulatory Counsel Cardinal Health, Inc. 1 1 Outline

More information

MISSOURI BOARD OF PHARMACY NEWSLETTER

MISSOURI BOARD OF PHARMACY NEWSLETTER MISSOURI BOARD OF PHARMACY NEWSLETTER FEBRUARY 2018 CONTENTS FY17 Annual Report...1 What Takes So Long?...3 Did You Know?...3 Inspection Tip...3 Rule Updates...5 Meet Our New Inspector!!...6 Disciplinary

More information

AN ACT. relating to the medical use of low-thc cannabis and the regulation. of related organizations and individuals; requiring a dispensing

AN ACT. relating to the medical use of low-thc cannabis and the regulation. of related organizations and individuals; requiring a dispensing Chapter 0 S.B. No. AN ACT relating to the medical use of low-thc cannabis and the regulation of related organizations and individuals; requiring a dispensing organization to obtain a license to dispense

More information

Reducing Opioid Deaths: Arizona s Emergency Declaration & Response

Reducing Opioid Deaths: Arizona s Emergency Declaration & Response Reducing Opioid Deaths: Arizona s Emergency Declaration & Response September 15, 2017 Sheila Sjolander, Assistant Director Arizona Department of Health Services Emergency Declaration On June 5, 2017, Arizona

More information

CHAPTER NINE INSULIN AND GLUCAGON ADMINISTRATION

CHAPTER NINE INSULIN AND GLUCAGON ADMINISTRATION CHAPTER NINE INSULIN AND GLUCAGON ADMINISTRATION SECTION I PURPOSE AND AUTHORITY A. REGULATORY AUTHORITY 1. These rules shall be known as the Arkansas Department of Education and Arkansas State Board of

More information

PHYSICAL MEDICINE AND REHABILITATION CSHCN SERVICES PROGRAM PROVIDER MANUAL

PHYSICAL MEDICINE AND REHABILITATION CSHCN SERVICES PROGRAM PROVIDER MANUAL PHYSICAL MEDICINE AND REHABILITATION CSHCN SERVICES PROGRAM PROVIDER MANUAL NOVEMBER 2017 CSHCN PROVIDER PROCEDURES MANUAL NOVEMBER 2017 PHYSICAL MEDICINE AND REHABILITATION Table of Contents 30.1 Enrollment......................................................................

More information

Tennessee. Prescribing and Dispensing Profile. Research current through November 2015.

Tennessee. Prescribing and Dispensing Profile. Research current through November 2015. Prescribing and Dispensing Profile Tennessee Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points

More information

Naloxone Access Statutes

Naloxone Access Statutes Naloxone Access Statutes Research current through August 30, 2015 This project was supported by Grant No. G15599ONDCP03A, awarded by the Office of National Drug Control Policy. Points of view or opinions

More information

SUBJECT: Opioid Overdose and Intranasal Naloxone Training for Law Enforcement: Train the Trainer Session: Queens County October 17, 2014

SUBJECT: Opioid Overdose and Intranasal Naloxone Training for Law Enforcement: Train the Trainer Session: Queens County October 17, 2014 ANDREW M. CUOMO GOVERNOR STATE OF NEW YORK DIVISION OF CRIMINAL JUSTICE SERVICES Alfred E. Smith Office Building 80 South Swan Street Albany, New York 12210 http://criminaljustice.ny.gov MICHAEL C. GREEN

More information

SANTA BARBARA COUNTY DEPARTMENT OF Behavioral Wellness A System of Care and Recovery

SANTA BARBARA COUNTY DEPARTMENT OF Behavioral Wellness A System of Care and Recovery Page 1 of 9 SANTA BARBARA COUNTY DEPARTMENT OF Behavioral Wellness A System of Care and Recovery Departmental Polley and Procedure Section Sub-section Alcohol and Drug Program (ADP) Effective: 7/11/2018

More information

Tri-County Region Opioid Trends Clackamas, Multnomah, and Washington, Oregon. Executive Summary

Tri-County Region Opioid Trends Clackamas, Multnomah, and Washington, Oregon. Executive Summary Tri-County Region Opioid Trends Clackamas, Multnomah, and Washington, Oregon 2016 Executive Summary 20.8 million people in the United States have a substance use disorder (not limited to opioids), equivalent

More information

TITLE NALOXONE STATEWIDE STANDING ORDER UPDATE & NARCAN ACCESS ONE-DAY EVENT

TITLE NALOXONE STATEWIDE STANDING ORDER UPDATE & NARCAN ACCESS ONE-DAY EVENT TITLE NALOXONE STATEWIDE STANDING ORDER UPDATE & NARCAN ACCESS ONE-DAY EVENT WELCOME Kate Gainer, PharmD Executive Vice President and CEO Iowa Pharmacy Association PRESENTER Kevin Gabbert, LISW, IAADC

More information

Protecting Children s Safety: How Prescription Drug Monitoring Programs Can Assist An Update Presenter: John L. Eadie Moderator: Cindy Rodgers

Protecting Children s Safety: How Prescription Drug Monitoring Programs Can Assist An Update Presenter: John L. Eadie Moderator: Cindy Rodgers Protecting Children s Safety: How Prescription Drug Monitoring Programs Can Assist An Update Presenter: John L. Eadie Moderator: Cindy Rodgers Audio is streaming through your computer speakers. If you

More information

Risk Evaluation And Mitigation Strategies:

Risk Evaluation And Mitigation Strategies: Risk Evaluation And Mitigation Strategies: The Experts Answer Questions from Health-System Pharmacists A midday symposium about the risk evaluation and mitigation strategies (REMS) required by the Food

More information

Controlled Substance Prescribing: A Physician s Guide. Bethanie Gamble, PharmD Department of Pharmacy Greenville Health System

Controlled Substance Prescribing: A Physician s Guide. Bethanie Gamble, PharmD Department of Pharmacy Greenville Health System Controlled Substance Prescribing: A Physician s Guide Bethanie Gamble, PharmD Department of Pharmacy Greenville Health System Objectives Review schedules of controlled substances and their propensity for

More information

FAQs about Changes to DHR Immunization Rules and Regulations

FAQs about Changes to DHR Immunization Rules and Regulations FAQs about Changes to DHR Immunization Rules and Regulations 1. What are the new immunization rules changes? The new immunization rules changes include 1 new definition and changes in 4 vaccine requirements.

More information

Prescription Medication Guidelines for Medical Providers in CorVel s CorCare and Care IQ Networks

Prescription Medication Guidelines for Medical Providers in CorVel s CorCare and Care IQ Networks Prescription Medication Guidelines for Medical Providers in CorVel s CorCare and Care IQ Networks Patient Health and Safety Guidelines Prescription Medications Policy Update / April 2017 In connection

More information

Student Number. PHARMACY 543 PHARMACY LAWS & ETHICS MIDTERM EXAMINATION 2 November 10, 1999

Student Number. PHARMACY 543 PHARMACY LAWS & ETHICS MIDTERM EXAMINATION 2 November 10, 1999 PHARMACY 543 PHARMACY LAWS & ETHICS MIDTERM EXAMINATION 2 November 10, 1999 Questions 1-25 are multiple choice; please record answers on Side 2 of a Standard Answer Sheet, Form 1158. Follow the instructions

More information

Submitted to the House Energy and Commerce Committee. Federal Efforts to Combat the Opioid Crisis

Submitted to the House Energy and Commerce Committee. Federal Efforts to Combat the Opioid Crisis STATEMENT FOR THE RECORD Submitted to the House Energy and Commerce Committee Federal Efforts to Combat the Opioid Crisis October 25, 2017 America s Health Insurance Plans 601 Pennsylvania Avenue, NW Suite

More information

4/10/2016. Legal & Policy Approaches to Reducing Opioid Poisonings. Overview. Background. Health Directors Legal Conference April 19, 2016

4/10/2016. Legal & Policy Approaches to Reducing Opioid Poisonings. Overview. Background. Health Directors Legal Conference April 19, 2016 Legal & Policy Approaches to Reducing Opioid Poisonings Health Directors Legal Conference April 19, 2016 Corey Davis Network for Public Health Law Overview Fatal opioid overdose is at epidemic levels Many

More information

States with Authority to Require Nonresident Pharmacies to Report to PMP

States with Authority to Require Nonresident Pharmacies to Report to PMP States with Authority to Require Nonresident Pharmacies to Report to PMP Research current through May 2016. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug

More information

Opioid Safety: Prescribing Guidelines, Quality Measures and Care Coordination Best-Practices

Opioid Safety: Prescribing Guidelines, Quality Measures and Care Coordination Best-Practices Opioid Safety: Prescribing Guidelines, Quality Measures and Care Coordination Best-Practices August 25, 2017 Presented by Michael Crooks, PharmD. Medication Safety and Care Coordination Task Lead 8/28/2017

More information

Preparing for Electronic Prescribing of Controlled Substances (EPCS) in New York

Preparing for Electronic Prescribing of Controlled Substances (EPCS) in New York Preparing for Electronic Prescribing of Controlled Substances (EPCS) in New York Ken Whittemore, Jr. R.Ph., MBA Senior VP, Professional & Regulatory Affairs Copyright Copyright 2015 by 2015 Surescripts,

More information

Kim Gonzales, Executive Director. Las Animas Huerfano Counties District Health Department

Kim Gonzales, Executive Director. Las Animas Huerfano Counties District Health Department Kim Gonzales, Executive Director Las Animas Huerfano Counties District Health Department Colorado's Public Health Act (SB 08 194) took effect in 2008, calling for major reforms to the state's governmental

More information

MARYLAND BOARD OF PHARMACY

MARYLAND BOARD OF PHARMACY MARYLAND BOARD OF PHARMACY CONTRACEPTION REGULATIONSAnd Other Legislative Initiatives THE ROAD FROM CONCEPTUALIZATION TO IMPLEMENTATION Deena Speights-Napata Executive Director Maryland Board of Pharmacy

More information

Prescription Drug Monitoring Program

Prescription Drug Monitoring Program California Department of Justice Prescription Drug Monitoring Program May, 2016 Health and Safety Code section 11165. (a) To assist health care practitioners in their efforts to ensure appropriate prescribing,

More information

The Wisconsin Prescription Drug Monitoring Program

The Wisconsin Prescription Drug Monitoring Program The Wisconsin Prescription Drug Monitoring Program DHS 2018 WI Opioid Forum April 12, 2018 Learning Objectives 1. How the WI epdmp supports healthcare professionals in making informed prescribing, dispensing

More information

DOUGLAS COUNTY GOVERNMENT POLICY FORM. To ensure a drug-free work environment within Douglas County Government.

DOUGLAS COUNTY GOVERNMENT POLICY FORM. To ensure a drug-free work environment within Douglas County Government. DOUGLAS COUNTY GOVERNMENT POLICY FORM SUBJECT DRUG-FREE WORKPLACE TITLE DRUG-FREE WORKPLACE POLICY NO. HR.6.10 APPROVAL DATE 1/1/11 REVISION DATE 1/16/18 PURPOSE: DEPARTMENT RESPONSIBLE: DEPARTMENT(S)

More information

January 2017 FEDERAL LAW CURRENT BOARD MEMBERS. June 24, Ben Kesner RPh Executive Director Shelley Bagwell RPh PMP Director.

January 2017 FEDERAL LAW CURRENT BOARD MEMBERS. June 24, Ben Kesner RPh Executive Director Shelley Bagwell RPh PMP Director. June 24, 2017 Ben Kesner RPh Executive Director Shelley Bagwell RPh PMP Director CURRENT BOARD MEMBERS January 2017 Richard Mazzoni RPh Amy Buesing RPh Neal Dungan RPh Joe Anderson RPh Teri Rolan RPh Cathleen

More information

2016 Dr. Douglas H. Kay CPE Symposium

2016 Dr. Douglas H. Kay CPE Symposium GREGORY CAMERON, R.Ph ASSISTANT PROFESSOR OF PHARMACY PRACTICE FIELD COORDINATOR COMMUNITY SITES HUSSON UNIVERSITY SCHOOL OF PHARMACY November 5, 2016 Please Silence All Electronic Equipment OBJECTIVES

More information

Take Home Naloxone: Law Update and Considerations for Pharmacy Professionals

Take Home Naloxone: Law Update and Considerations for Pharmacy Professionals Take Home Naloxone: Law Update and Considerations for Pharmacy Professionals Clint Ross, PharmD, BCPP Clinical Pharmacy Specialist Psychiatry Residency Program Director Psychiatric Pharmacy Medical University

More information

The Sale of Cannabis in Pharmacies. Michael H. Ghobrial, PharmD, JD Associate Director, Health Policy American Pharmacists Association

The Sale of Cannabis in Pharmacies. Michael H. Ghobrial, PharmD, JD Associate Director, Health Policy American Pharmacists Association The Sale of Cannabis in Pharmacies Michael H. Ghobrial, PharmD, JD Associate Director, Health Policy American Pharmacists Association Development This activity was developed by the American Pharmacists

More information

On December 27, 2017, the Lieutenant Governor signed into law several new requirements

On December 27, 2017, the Lieutenant Governor signed into law several new requirements OPIOID Alert MICHIGAN OSTEOPATHIC ASSOCIATION JANUARY 2018 On December 27, 2017, the Lieutenant Governor signed into law several new requirements aimed at combating the opioid epidemic. On the following

More information

The Wisconsin Prescription Drug Monitoring Program. WI PDMP Timeline. PDMP Overview. What is a PDMP? PDMPs Across the Nation. Wisconsin.

The Wisconsin Prescription Drug Monitoring Program. WI PDMP Timeline. PDMP Overview. What is a PDMP? PDMPs Across the Nation. Wisconsin. The Wisconsin Prescription Drug Monitoring Program Wisconsin Nurses Association Jail Health Care Conference May 21, 2018 WI PDMP Timeline PDMP Overview January 2013 WI PDMP operational April 2017 WI epdmp

More information

TN Opioid Program. Erica Schlesinger, Pharm.D

TN Opioid Program. Erica Schlesinger, Pharm.D TN Opioid Program Erica Schlesinger, Pharm.D Nothing to disclose Disclosures TN Together Governor Haslam s Plan Prevention Establishes limits, decreases supply and dosage of prescription opioids Limits

More information

Legislative and Regulatory Update Michael Baxter APhA Director, Regulatory Affairs

Legislative and Regulatory Update Michael Baxter APhA Director, Regulatory Affairs Legislative and Regulatory Update 2018 Michael Baxter APhA Director, Regulatory Affairs 1 CPE Information and Disclosures Michael Baxter declares no conflicts of interest, real or apparent, and no financial

More information

SAFE OPIOID PRESCRIBING C.U.R.E.S. PROGRAM

SAFE OPIOID PRESCRIBING C.U.R.E.S. PROGRAM Sorin Buga, MD Associate Clinical Professor Department of Supportive Care City of Hope National Medical Center SAFE OPIOID PRESCRIBING C.U.R.E.S. PROGRAM Click to edit Master Presentation Date Disclosure

More information

LEGAL ASPECTS of MEDICAL MARIJUANA Florida Nurse Practitioner Network Annual Conference September 17, 2018

LEGAL ASPECTS of MEDICAL MARIJUANA Florida Nurse Practitioner Network Annual Conference September 17, 2018 LEGAL ASPECTS of MEDICAL MARIJUANA Florida Nurse Practitioner Network Annual Conference September 17, 2018 DISCLAIMER The material presented is general legal information and is not legal advice. Specific

More information

STATE & FEDERAL EFFORTS TO COMBAT THE OPIOID EPIDEMIC & IMPACT ON COMPLIANCE PROGRAMS GRACE E. REBLING OSBORN MALEDON P.A.

STATE & FEDERAL EFFORTS TO COMBAT THE OPIOID EPIDEMIC & IMPACT ON COMPLIANCE PROGRAMS GRACE E. REBLING OSBORN MALEDON P.A. STATE & FEDERAL EFFORTS TO COMBAT THE OPIOID EPIDEMIC & IMPACT ON COMPLIANCE PROGRAMS GRACE E. REBLING OSBORN MALEDON P.A. Arizona Corporate Counsel Presentation May 8, 2018 Agenda 1. Overview of the Opioid

More information

NYSHFA/NYSCAL 16 th Annual Nurse Leadership Conference. Timothy J. Dewey Sr. Investigator NYS Bureau of Narcotic Enforcement.

NYSHFA/NYSCAL 16 th Annual Nurse Leadership Conference. Timothy J. Dewey Sr. Investigator NYS Bureau of Narcotic Enforcement. NYSHFA/NYSCAL 16 th Annual Nurse Leadership Conference Timothy J. Dewey Sr. Investigator NYS Bureau of Narcotic Enforcement May 2, 2018 1 May 2, 2018 2 Bureau Overview May 2, 2018 3 HISTORY 1850--Bureau

More information

APPENDIX 1 State Summary Tables

APPENDIX 1 State Summary Tables APPENDIX 1 State Summary Tables X SUMMARY TABLE Element 1: Affected HCW Health Care Worker means all persons, whether paid or unpaid, including but not limited to employees, staff, contractors, clinicians,

More information

Ontario s Narcotics Strategy

Ontario s Narcotics Strategy Ontario s Narcotics Strategy Ontario Public Drug Programs Ministry of Health and Long-Term Care January 31, 2012 Ontario Harm Reduction Distribution Program Conference 2012 1 Background The Need for Action

More information

RULES OF THE TENNESSEE BOARD OF PHARMACY CHAPTER DRUG DONATION REPOSITORY PROGRAM TABLE OF CONTENTS

RULES OF THE TENNESSEE BOARD OF PHARMACY CHAPTER DRUG DONATION REPOSITORY PROGRAM TABLE OF CONTENTS RULES OF THE TENNESSEE BOARD OF PHARMACY CHAPTER 1140-17 DRUG DONATION REPOSITORY PROGRAM TABLE OF CONTENTS 1140-17-.01 Definitions 1140-17-.02 Purpose 1140-17-.03 Eligibility Criteria for Program Participation

More information

DRUG FREE WORKPLACE POLICY

DRUG FREE WORKPLACE POLICY GENERAL STATEMENT DRUG FREE WORKPLACE POLICY Kitsap County Government is obligated and committed to provide our employees and the citizens of Kitsap County with an alcohol and drug free, healthy, safe,

More information